Biodelivery Sciences International (BDSI) 10-Q2009 Q3 Quarterly report

Filed: 3 Nov 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Accentia, Army, asserted, ASU, Bankruptcy, BDSI, begun, Benckiser, BREAKYLTM, candidate, Carolina, Chapter, clarified, Code, demand, desirable, director, Dr, Emezine, enable, entitled, eventuate, exemption, exhibit, explore, faced, forward, fungicidal, Granisetron, hand, Healthcare, infrastructure, Institute, Jersey, Jr, laboratory, Lastly, located, Mannino, marketplace, merit, methodology, moving, nausea, Newark, nongovernmental, North, opportunistically, oral, owner, President, Raleigh, Raphael, Reckitt, Reed, Release, reorganize, replacement, reversion, size, smaller, spending, stand, steering, strongly, study, TEAMM, toGoodwill, Triptan, UK, unanticipated, uncertain, Update, vacated, Vice, voluntary, vomiting, Walter

Removed: aggregate, agreed, April, consumed, cycle, device, disclose, Doyen, EITF, Emerging, evidence, FAS, Force, framework, FSP, fully, identifying, Issue, lead, life, machine, maximize, Medipharm, minimize, multiple, NIH, Operation, perform, proceed, recognize, reduced, Task

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BDSI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

BIODELIVERY SCIENCES INTERNATIONAL, INC.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioDelivery Sciences International, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark A. Sirgo, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Mark A. Sirgo

Mark A. Sirgo

President and Chief Executive Officer

November 2, 2009

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.